Key result
Pharmacological management of hyponatremia lacks comparative trial data on patient-relevant outcomes, requiring caution against overly rapid serum sodium correction.
This review highlights the lack of comparative trial data for hyponatremia treatments and emphasizes the need for studies focusing on patient-relevant outcomes rather than just serum sodium correction.
Answers are grounded in this paper and cite their sources.
Guideline discrepancies in hyponatremia pharmacotherapy urge individualized caution; leaves open harmonized recommendations pending prospective trials.
INTRODUCTION: Hyponatremia is the most common electrolyte disorder with a prevalence of up to 30% in hospitalized patients. Furthermore, it is associated with increased morbidity and mortality. AREAS COVERED: This review discusses the efficacy and side effects of the currently available treatment options for hyponatremia and the differences in the pharmacological approach between the European and USA guidelines. Additionally, the authors provide their expert perspectives on current treatment strategies and what they expect from this field in the future. EXPERT OPINION: Several pharmacological options are available for the treatment of hyponatremia, but data from trials examining and comparing these treatments are missing. Regarding chronic hyponatremia, the role of vaptans should be further analyzed, focusing on comparisons with other active treatments on patient-relevant outcomes and not only on serum sodium concentration. Clinicians should be cautious to an overly rapid increase in serum sodium levels with all available treatment strategies. Finally, it is important to ascertain whether correction of serum sodium levels improves mortality in hyponatremic patients.
No takes yet. Share an insight, caveat, or question.
Filippatos et al. (2018) conducted a review in Hyponatremia. Pharmacological management was evaluated. Pharmacological management of hyponatremia lacks comparative trial data on patient-relevant outcomes, requiring caution against overly rapid serum sodium correction.
Synapse has enriched 10 related papers. Consider them for comparative context: